Collaboration with leading hyperscale data center company will support Trinovium's technical and commercial readiness through development of cooling technologies for next-generation AI and modular ...

A newly public biotech is betting its entire future on a single antibody platform designed to silence what scientists call ...

Amgen, Gilead and Vertex all show up in the same note, but the bank isn't treating them equally.

UC Santa Cruz deepens industry engagement to underscore its vital role in contributing basic research and tomorrow’s talent, convening its first international RNA biotech conference on August 18 ...

Positive readouts in cancer and cardiac drug trials could keep the rally going. Sizing up the stakes for Merck, Moderna, ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Scientists at the Department of Energy's Oak Ridge National Laboratory have created a platform that pinpoints genetic ...

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce ...

Biotech, especially small-cap names, is experiencing renewed optimism as macro and policy headwinds subside. Read more on ...

This is not possible without a steadfast commitment from our partners in the federal government and private industry. It’s important to acknowledge and evaluate the current constraints. On the ...

Effective translation of the benefits of NRDL inclusion: 3 indications of 佳泰莱® and 达泰莱® have been included in the 2025 NRDL, which officially took effect on January 1, 2026. This marks 佳泰莱® the only ...